Aligos therapeutics to present at the jefferies 2022 healthcare conference

South san francisco, calif., may 23, 2022 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that lawrence m. blatt, ph.d., mba, chairman and ceo of aligos, will present in at the jefferies healthcare conference on wednesday, june 8, 2022, at 3:30 pm et at the marriot marquis in new york city.
ALGS Ratings Summary
ALGS Quant Ranking